Target intelligence / Profile preview

Extracellular matrix and serum proteins at the material–tissue interface

Molecular classification
Extracellular matrix proteins, Serum proteins, Cell adhesion molecules, Other
01

Overview

The extracellular matrix and serum proteins at the material–tissue interface represent the dynamic layer of biological molecules that coat a synthetic surface upon implantation. This interface is primarily formed through the spontaneous adsorption of proteins from blood or interstitial fluid, a process governed by the Vroman effect where high-abundance proteins are gradually replaced by those with higher surface affinity (Wilson et al., 2005). The specific composition, orientation, and conformation of these adsorbed proteins, such as fibrinogen, fibronectin, and vitronectin, serve as the primary signaling cues for host cells (Anderson et al., 2008). These cues determine the progression of the foreign body response, ranging from successful tissue integration to chronic inflammation and fibrous encapsulation. While not a single therapeutic target in the classical sense, this interface is a focal point for biomaterial engineering, where surface modifications like PEGylation or zwitterionic coatings are employed to control protein interactions and improve device biocompatibility (Castner & Ratner, 2002).

Other names
Protein coronaAdsorbed protein layerBiomaterial-associated protein layerVroman effect interface
02

Mechanism of action

Surface passivation and modulation of host immune recognition to prevent fibrous encapsulation or thrombosis.

03

Biological functions

Cell adhesionForeign body responseInflammationCoagulationTissue integration
04

Disease associations

Foreign body reactionFibrosisImplant failureThrombosisInfection
05

Safety considerations

Chronic inflammationFibrous encapsulationThrombosisBiofilm formationDevice rejection
06

Interacting drugs

Heparin

3 more in the full profile.

07

Biomarkers

FibrinogenC-reactive proteinInterleukin-6Complement component C3a

Beyond the preview

Go deeper on Extracellular matrix and serum proteins at the material–tissue interface.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Extracellular matrix and serum proteins at the material–tissue interface.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call